LN-039434
Doxazosin Related Compound F (15 mg) (N,N'-bis(1,4-benzodioxane-2-carbonyl)piperazine) , 0.95 , 617677-53-9
Update time: 2023-04-23
PRODUCT Properties
| Melting point: | > 150°C (Dec) |
| Boiling point: | 646.9±55.0 °C(Predicted) |
| Density | 1.368±0.06 g/cm3(Predicted) |
| storage temp. | -20°C Freezer, Under inert atmosphere |
| solubility | Chloroform (Slightly), Dichloromethane (Slightly) |
| pka | -1.53±0.70(Predicted) |
| form | Solid |
| color | White to Pale Beige |
| InChI | InChI=1S/C22H22N2O6/c25-21(19-13-27-15-5-1-3-7-17(15)29-19)23-9-11-24(12-10-23)22(26)20-14-28-16-6-2-4-8-18(16)30-20/h1-8,19-20H,9-14H2 |
| InChIKey | RYWJYOGVNZEBKW-UHFFFAOYSA-N |
| SMILES | N1(C(C2COC3=CC=CC=C3O2)=O)CCN(C(C2COC3=CC=CC=C3O2)=O)CC1 |
Description and Uses
N,N’-Bis(1,4-benzodioxane-2-carbonyl)piperazine (Doxazosin EP Impurity C) is an impurity in the synthesis of Doxazosin (D537500), a selective α1-adrenoceptor antagonist. Doxazosin relaxes smooth muscles of the prostate.
Safety
| HS Code | 2934990002 |
